Back to search

Article

Construction of an immune-related lncRNA signature pair for predicting oncologic outcomes and the sensitivity of drugs to treat adverse reactions to immunotherapy in lung adenocarcinoma

2021-10-19

Abstract excerpt

<h4>Background: </h4> Although immunotherapy has shown clinical activity in lung adenocarcinoma (LUAD), LUAD prognosis has been a perplexing problem. We aimed to construct an immune-related lncRNA pair (IRLPs) score for LUAD and identify the best drugs to treat immune-related adverse events (ir AEs). Methods Based on The Cancer Genome Atlas (TCGA) LUAD dataset, IRLPs were identified to construct an IRLPs scoring...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6e31006e-499d-54cf-9001-1f484a3a2b34
DOI
10.21203/rs.3.rs-960382/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Construction of an immune-related lncRNA signature pair for predicting oncologic outcomes and the sensitivity of drugs to treat adverse reactions to immunotherapy in lung adenocarcinomaDOI 10.21203/rs.3.rs-960382/v1
Development of an Immune-Related Gene Pairs Signature for Predicting Clinical Outcome in Lung AdenocarcinomaSemantic proximity
Development of an immune-related gene pairs signature for predicting clinical outcome in lung adenocarcinomaSemantic proximity
IRGS: an immune-related gene classifier for lung adenocarcinoma prognosisSemantic proximity
Prediction of Prognosis, Efficacy of Lung Adenocarcinoma by Machine Learning Model Based on Immune and Metabolic Related GenesSemantic proximity
Immunogenic Cell Death-based prognostic model for predicting the response to immunotherapy and common therapy in lung adenocarcinomaSemantic proximity
Drug resistance related genes in lung adenocarcinoma predict patient prognosis and influence the tumor microenvironmentSemantic proximity
Exploration of the Immune-related Gene Set Score (IRGS) in the Prognosis and Immunotherapy of Lung Adenocarcinoma (LUAD)Semantic proximity
Bioinformatics analysis of an immunotherapy responsiveness-related gene signature in predicting lung adenocarcinoma prognosisSemantic proximity
Exploration of the prognostic signature reflecting tumor microenvironment of lung adenocarcinoma based on immunologically relevant genesSemantic proximity
Construction of a novel prognostic model for evaluation of immune infiltration and immunotherapy in lung adenocarcinomaSemantic proximity
Identification of an immune-related genes signature in lung adenocarcinoma to predict survival and response to immune checkpoint inhibitorsSemantic proximity
Subtype classification based on t cell proliferation-related regulator genes and risk model for predicting outcomes of lung adenocarcinomaSemantic proximity
Select a neighboring publication to make it the new centre.